dsm-firmenich FY 2025 shows “strong” beauty & fragrance performance
Key takeaways
- dsm-firmenich’s Perfume & Beauty segment showed steady growth, with a strong performance from Fine Fragrances.
- The company has made strides in reducing its carbon footprint and increasing the use of renewable resources in beauty formulations.
- dsm-firmenich is optimistic about continued growth in its beauty and personal care segment.
In its latest financial results, global player in health, nutrition, and beauty, dsm-firmenich, has reported significant growth across various sectors, with a focus on the beauty and personal care division.
Its 2025 financial results show a 5% increase in adjusted EBITDA, driven by successful cost and revenue synergies and robust margins across key business areas, including Taste, Texture & Health, and Health, Nutrition & Care.
Meanwhile, dsm-firmenich’s Perfumery & Beauty (P&B) segment achieved 3% organic sales growth, with strong performance in fine fragrances.
Beauty sector’s strong contribution to growth
The beauty and personal care division has proven to be a key player in dsm-firmenich’s overall growth strategy. With heightened consumer demand for sustainable and innovative beauty solutions, the division’s performance has exceeded expectations.
The company has led in innovation, developing new products that cater to evolving consumer preferences for sustainability, clean beauty, and personalization.
Notably, consumer interest in personalized beauty has surged, with dsm-firmenich providing tailored beauty solutions through data-driven insights and tailored product recommendations. Their high-performance ingredients are also increasingly sought after by top global beauty brands.
In December, the company created a fragrance collection that translated Pantone’s 2026 color of the year into scent. Utilizing dsm-firmenich’s creations, smart home fragrance brand Pura released a scent inspired by the color of the year “Cloud Dancer.” The fragrance was developed with perfumers Clement Gavarry and Erwan Raguenes from dsm-firmenich.
Earlier this week, Personal Care Insights reported that dsm-firmenich is continuing its expansion in the Middle East with the opening of a fragrance space in Riyadh, Saudi Arabia, and the launch of a scent range. The space, developed in partnership with fragrance concept store Villa Po One, will serve as a hub for perfume production. The location aims to provide perfumers with ingredients, tools, and access to narratives to enable contemporary scent production.
Strategic roadmap
Following the completion of dsm-firmenich’s strategic roadmap to become a leading consumer-focused company in nutrition, health, and beauty, dsm-firmenich will now focus on three strategic priorities: “Grow what we have,” “anchor what we do,” and “deliver on our promises.”
Fragrance innovation remains a stronghold for dsm-firmenich, with eco-conscious fragrance offerings meeting the growing demand for more sustainable products in the industry.The company is on track to achieve its mid-term ambitions, including synergy delivery, disciplined capital allocation, and strong cost, cash, and operating working capital efficiency, to generate sustainable value for all stakeholders.
The company’s mid-term financial ambitions include 5%–7% organic sales growth, an adjusted EBITDA margin of 22%–23%, a cash-to-sales conversion greater than 10%, and the delivery of intended synergies.
dsm-firmenich is on track to achieve its target merger synergies, which are expected to contribute approximately €350 million (US$374.5 million) to adjusted EBITDA. In 2025, the company realized around €65 million (US$69.55 million) in cost synergies, bringing the total to about €175 million (US$187.25 million) for the group.
Additionally, dsm-firmenich realized around €100 million (US$107 million) in revenue synergies during 2025, bringing the total to approximately €175 million (US$187.25 million). This contributed around €60 million (US$64.2 million) to adjusted EBITDA cumulatively since the merger, of which approximately €35 million (US$37.45 million) was realized in 2025. The remaining €115 million (US$123.05 million) in adjusted EBITDA from revenue synergies is expected to be realized through 2027.
According to Dimitri de Vreeze, CEO, the divestment of Animal Nutrition & Health marks the final step in executing the company’s strategic roadmap to becoming a leading consumer-focused company in nutrition, health, and beauty.
“This is an important milestone for the company. It enables us to fully focus on our core strengths and the execution of our strategy to deliver on our mid-term ambitions, while creating sustainable long-term value for all stakeholders,” he says.
“From a business perspective, we made good progress in improving the performance of our three continuing business operations. Our innovative solutions play a critical role in essential, everyday consumer products, demonstrating the strength and resilience of our portfolio, particularly against the more challenging macroeconomic backdrop in the second half of 2025.”
De Vreeze believes dsm-firmenich is “well-positioned for 2026,” supported by innovation-driven growth, continued delivery of sales synergies, continued focus on cash generation, and capital discipline.
Future outlook
The company remains optimistic about the future of its beauty and personal care segment, forecasting continued growth as the market recovers from the global disruptions of the past few years.
As consumers demand more from their beauty products, dsm-firmenich plans to continue expanding its product offerings while staying at the edge of scientific innovation.
The company’s pipeline of new technologies and ingredients is expected to further bolster its position in the beauty sector.
